Please use this identifier to cite or link to this item:
Authors: Farmakis, Ioannis T.
Barco, Stefano
Mavromanoli, Anna C.
Agnelli, Giancarlo
Cohen, Alexander T.
Giannakoulas, George
Mahan, Charles E.
Konstantinides, Stavros V.
Valerio, Luca
Title: Cost‐of‐illness analysis of long‐term health care resource use and disease burden in patients with pulmonary embolism : insights from the PREFER in VTE registry
Online publication date: 10-Feb-2023
Year of first publication: 2022
Language: english
Abstract: Background As mortality from pulmonary embolism (PE) decreases, the personal and societal costs among survivors are receiving increasing attention. Detailing this burden would support an efficient public health resource allocation. We aimed to provide estimates for the economic and disease burden of PE also accounting for long‐term health care use and both direct and indirect costs beyond the acute phase. Methods and Results This is a cost‐of‐illness analysis with a bottom‐up approach based on data from the PREFER in VTE registry (Prevention of Thromboembolic Events—European Registry in Venous Thromboembolism). We calculated direct (clinical events and anticoagulation) and indirect costs (loss of productivity) of an acute PE event and its 12‐month follow‐up in 2020 Euros. We estimated a disability weight for the 12‐month post‐PE status and corresponding disability adjusted life years presumably owing to PE. Disease‐specific costs in the first year of follow‐up after an incident PE case ranged between 9135 Euros and 10 620 Euros. The proportion of indirect costs was 42% to 49% of total costs. Costs were lowest in patients with ongoing cancer, mainly because productivity loss was less evident in this already burdened population. The calculated disability weight for survivors who were cancer free 12 months post‐PE was 0.017, and the estimated disability adjusted life years per incident case were 1.17. Conclusions The economic burden imposed by PE to society and affected patients is considerable, and productivity loss is its main driver. The disease burden from PE is remarkable and translates to the loss of roughly 1.2 years of healthy life per incident PE case.
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
Version: Published version
Publication type: Zeitschriftenaufsatz
Document type specification: Scientific article
License: CC BY-NC-ND
Information on rights of use:
Journal: Journal of the American Heart Association
Pages or article number: e027514
Publisher: Wiley-Blackwell
Publisher place: New York, NY
Issue date: 2022
ISSN: 2047-9980
Publisher DOI: 10.1161/JAHA.122.027514
Appears in collections:DFG-491381577-G

Files in This Item:
  File Description SizeFormat
costofillness_analysis_of_lon-20230131122343865.pdf798.92 kBAdobe PDFView/Open